secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001739410-25-000021
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Rallybio receives Nasdaq bid price deficiency notice; faces potential delisting
-------------------------------------------------------------------------------

- Notice on Feb 24, 2025: closing bid price below $1.00 for 30 consecutive business days.
- Company has 180 days, until August 25, 2025, to regain compliance by closing at $1.00+ for 10 days.
- If not cured, may qualify for additional 180-day period by transferring to Nasdaq Capital Market.
- Failure to regain compliance could lead to delisting and potential appeal to Nasdaq Hearings Panel.
- No immediate impact on trading; stock continues to list on Nasdaq under other requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000173941025000021/0001739410-25-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000173941025000021/rlyb-20250224.htm
  HTML page:      https://secwatch.observer/filing/0001739410-25-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer